One World Cannabis discovers, develops, and commercializes cannabis-based therapeutic products and treatments.

One World Cannabis intends to investigate specific cannabis strains, combinations of the cannabinoids THC and CBD, and optimal dosages.The companys first clinical trials will explore potential treatments for fibromyalgia, psoriasis, basal cell carcinoma, post-traumatic stress disorder, and seizures.

The second set of clinical trials will focus on the development of cannabis medicines for Crohns disease, Parkinsons disease, Tourettes syndrome, migraines, chronic pain, Alzheimers disease, pediatric epilepsy, prostate cancer, and diabetes.One World Cannabis is a wholly owned Israeli subsidiary of OWC Pharmaceutical Research Corp.